Tolga Agdirlioglu

Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial

David E. Kandzari, Michael Böhm, Felix Mahfoud et al. · The Lancet · 2018 · 776 citations

Medicine, Cardiology, Pharmacology +11

Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial

Raymond R. Townsend, Felix Mahfoud, David E. Kandzari et al. · The Lancet · 2017 · 734 citations

Medicine, Cardiology, Nephrology +10

Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial

Michael Böhm, Kazuomi Kario, David E. Kandzari et al. · The Lancet · 2020 · 587 citations

Medicine, Cardiology, Nephrology +8

Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial

Michel Azizi, Kintur Sanghvi, Manish Saxena et al. · The Lancet · 2021 · 416 citations · Full text

Pharmacy, Cardiology, Pharmacotherapy +12

Low-Voltage Myocardium-Guided Ablation Trial of Persistent Atrial Fibrillation

Yan Huo, Thomas Gaspar, Robert Schönbauer et al. · NEJM Evidence · 2022 · 261 citations

Medicine, Cardiology, Clinical Cardiology +11